Skip to main content
Bioventus Inc. logo

Bioventus Inc. — Investor Relations & Filings

Ticker · BVS ISIN · US09075A1088 US Manufacturing
Filings indexed 433 across all filing types
Latest filing 2025-12-04 Regulatory Filings
Country US United States of America
Listing US BVS

About Bioventus Inc.

https://www.bioventus.com/

Bioventus Inc. is a global medical device company focused on developing and commercializing innovations for active healing, particularly in orthopedics. The company's operations are structured around three segments: Pain Treatments, Restorative Therapies, and Surgical Solutions. Its portfolio includes clinically differentiated, cost-efficient, and minimally invasive treatments designed to help patients resume active lives. Key products include hyaluronic acid (HA) joint pain injection therapies such as DUROLANE®, GELSYN-3®, and SUPARTZ FX®; the StimRouter® neuromodulation system for chronic peripheral nerve pain; the EXOGEN® Ultrasound Bone Healing System; and a comprehensive range of surgical orthobiologics. Bioventus aims to provide solutions that improve patient outcomes and quality of life.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2025
Regulatory Filings
2025-12-04 English
FORM 3
Director's Dealing
2025-11-26 English
8-K
Regulatory Filings
2025-11-17 English
FORM 4
Director's Dealing
2025-11-10 English
Regulatory Filings 2025
Regulatory Filings
2025-11-07 English
10-Q
Interim / Quarterly Report Q3 2025
2025-11-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.